Menu

1 / 2

Capricor Therapeutics, Inc. (CAPR) Q1 2026 Earnings Call Transcript

Seeking Alpha·SA Transcripts·6 months ago
#L1kYqsAr
#source#chevron#alpha#research#statements
Reading 0:00
15s threshold

Capricor Therapeutics, Inc. ( CAPR ) Q1 2026 Earnings Call May 12, 2026 4:30 PM EDT

Company Participants

Anthony Bergmann - CFO & Corporate Treasurer

Linda Marbán - Co-Founder, President, CEO & Director

Conference Call Participants

Leland Gershell - Oppenheimer & Co. Inc., Research Division

Edward Tenthoff - Piper Sandler & Co., Research Division

Kristen Kluska - Cantor Fitzgerald & Co., Research Division

Madison Wynne El-Saadi - B. Riley Securities, Inc., Research Division

Michael Okunewitch - Maxim Group LLC, Research Division

Catherine Novack - JonesTrading Institutional Services, LLC, Research Division

Matthew Venezia - Alliance Global Partners, Research Division

Boobalan Pachaiyappan - ROTH Capital Partners, LLC, Research Division

Presentation

Operator

Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics First Quarter 2026 Conference Call.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.